[CITATION][C] 903 TZP-102-Cl-G003 Phase 2B Study Results: Oral TZP-102 Once Daily for 12 Weeks in Patients With Diabetic Gastroparesis
RW McCallum, E Mondou, J Quinn, C Cosentino… - Gastroenterology, 2013 - infona.pl
903 TZP-102-Cl-G003 Phase 2B Study Results: Oral TZP-102 Once Daily for 12 Weeks in
Patients With Diabetic Gastroparesis × Close The Infona portal uses cookies, ie strings of text
saved by a browser on the user's device. The portal can access those files and use them to
remember the user's data, such as their chosen settings (screen view, interface language,
etc.), or their login data. By using the Infona portal the user accepts automatic saving and using
this information for portal operation purposes. More information on the subject can be found …
Patients With Diabetic Gastroparesis × Close The Infona portal uses cookies, ie strings of text
saved by a browser on the user's device. The portal can access those files and use them to
remember the user's data, such as their chosen settings (screen view, interface language,
etc.), or their login data. By using the Infona portal the user accepts automatic saving and using
this information for portal operation purposes. More information on the subject can be found …